Could GLP-1RAs improve outcomes for patients with chronic migraine?
Expert Review of Clinical Pharmacology · 03.08.2026 · 19 (8) · 697-700
DOI: 10.1080/17512433.2026.2710153 ↗Kurz gefasst
Editorial in der Zeitschrift Expert Review of Clinical Pharmacology, online erschienen am 28.07.2026. Verfasst von Tsung-Wei Hou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA.
- Department of Neurology, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan.
Zitieren
APA
Hou, T. W., Acar, V., & Yuan, H. (2026). Could GLP-1RAs improve outcomes for patients with chronic migraine?. Expert Review of Clinical Pharmacology, 19(8), 697-700. https://doi.org/10.1080/17512433.2026.2710153
Vancouver
Hou TW, Acar V, Yuan H. Could GLP-1RAs improve outcomes for patients with chronic migraine?. Expert Review of Clinical Pharmacology. 2026;19(8):697-700. doi:10.1080/17512433.2026.2710153
BibTeX
@article{Hou2026,
author = {Hou, Tsung-Wei and Acar, Vitoria and Yuan, Hsiangkuo},
title = {Could GLP-1RAs improve outcomes for patients with chronic migraine?},
journal = {Expert Review of Clinical Pharmacology},
year = {2026},
volume = {19},
number = {8},
pages = {697--700},
doi = {10.1080/17512433.2026.2710153}
}
EUVIMED